Pharmacogenetics - Genetic protocol

It might be possible to investigate side effects and pharmacokinetic factors in a non-patient population, in which case standard genetic methodologies could (conceivably) be used.

Otherwise, restriction to a group of subjects all diseased and receiving the drug effectively rules out consideration of related subjects.

Realistically, pharmacogenetic studies are likely to rely on association methods.

In pharmacogenetic studies, when considering responders and non- responders, a "mirrored" design can be applied to both TDT and sibling association tests.